Profil bibliographique

Lotte Westerink

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

16Publications signalées

16Citations signalées

3Affiliations récentes

Institutions déclarées

AstraZeneca (United Kingdom)AstraZeneca (Singapore)AstraZeneca (Switzerland)

Domaines associés

Eosinophilic EsophagitisEosinophilic Disorders and SyndromesVasculitis and related conditionsHealth Systems, Economic Evaluations, Quality of LifeLung Cancer Treatments and Mutations

Publications récentes

Accès ouvert 2026 articleOpenAlex

Healthcare resource utilisation and associated costs in patients with eosinophilic granulomatosis with polyangiitis in England: A retrospective observational cohort study

Salman H. Siddiqui, Bo Ding, Paul Dolin, Chris Edmonds et autres

0 citationsWorld Allergy Organization Journal

Accès ouvert 2026 articleOpenAlex

Patient Journey, Treatment Patterns, and Disease Burden of Patients With Idiopathic Hypereosinophilic Syndrome

Juliana Schwaab, Paul Dolin, Bo Ding, Priya Jain et autres

0 citationseJHaem

Accès ouvert 2026 dissertationOpenAlex

The value of targeted therapies in non-small-cell lung cancer

Lotte Westerink

0 citations

Accès ouvert 2026 articleOpenAlex

Epidemiology, clinical management, and outcomes in patients with eosinophilic granulomatosis with polyangiitis in England: A retrospective observational cohort study

Salman Siddiqui, Bo Ding, Paul Dolin, Chris Edmonds et autres

0 citationsJournal of Allergy and Clinical Immunology Global

Accès ouvert 2026 articleOpenAlex

Real-world disease burden, patient journey and treatment patterns in eosinophilic granulomatosis with polyangiitis in Europe and the USA

Robert Spiera, Paul Dolin, Bo Ding, Priya Jain et autres

0 citationsEULAR Rheumatology Open

Accès ouvert 2025 articleOpenAlex

Estimation of Health Utility Values for Eosinophilic Granulomatosis With Polyangiitis

Bhovina Buguth, Jacqui Bernarde, Daniel Aggio, Arya Pimprikar et autres

0 citationsPharmacoEconomics - Open

2025 conference-abstractOpenAlex

Healthcare resource utilization (HCRU) and costs in patients with eosinophilic granulomatosis with polyangiitis (EGPA): a retrospective observational cohort study in England

Salman Siddiqui, Bo Ding, Paul Dolin, Lotte Westerink et autres

0 citations

2025 conference-abstractOpenAlex

EGPA disease burden in Europe and US: evidence from real-world clinical practice

Bo Ding, Robert Spiera, Paul Dolin, Lotte Westerink et autres

0 citations

Accès ouvert 2024 articleOpenAlex

Trends in NICE technology appraisals of non-small cell lung cancer drugs over the last decade

Lotte Westerink, Sharon Wolters, Guiling Zhou, Arjan Jacobus Postma et autres

3 citationsThe European Journal of Health Economics

Accès ouvert 2022 articleOpenAlex

Cost-Effectiveness of Nintedanib for Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)

Lotte Westerink, Jelmer Lennart Jens Nicolai, Maarten J. Postma, Job F. M. van Boven et autres

3 citationsPharmacoEconomics - Open

2022 articleOpenAlex

POSB2 A Targeted Review of Published Meta-Analyses for LDL-C Lowering Treatments Beyond Statins: Bempedoic Acid, Ezetimibe, and PCSK9-Inhibitors Including Inclisiran

Alexander V. van Schoonhoven, Georgios Spentzouris, Lotte Westerink, A Tiemens et autres

0 citationsValue in Health

2020 articleOpenAlex

PRS5 Cost-Effectiveness of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD) in the Netherlands

Lotte Westerink, J. J. Nicolaï, Maarten J. Postma, Job F. M. van Boven et autres

0 citationsValue in Health

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.